Promotions & Moves

Rentschler Biotechnologie Names CEO

Mathias has more than 25 years of pharma and biopharma experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Frank Mathias has been appointed chief executive officer of Rentschler Biotechnologie, effective 1 April 2016. Dr. Mathias was previously a member of the company’s supervisory board.   Former chief executive, Dr. Nikolaus F. Rentschler, is moving to the supervisory board to oversee further expansion of the Rentschler group.   Dr. Mathias has more than 25 years of experience in the pharma and biopharma industries. He served as chief executive officer of Servier Deutschland and Amgen Deuts...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters